第一单位：
Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá 110111, Colombia.;Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá 110121, Colombia.
作者：
Camila,Ordóñez-Reyes [1]
;
Juan Esteban,Garcia-Robledo [2]
;
Diego F,Chamorro [1]
;
Andrés,Mosquera [3]
;
Liliana,Sussmann [4]
;
Alejandro,Ruiz-Patiño [1]
;
Oscar,Arrieta [5]
;
Lucia,Zatarain-Barrón [5]
;
Leonardo,Rojas [3]
;
Alessandro,Russo [6]
;
Diego,de Miguel-Perez [7]
;
Christian,Rolfo [7]
;
Andrés F,Cardona [8]
作者单位：
Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá 110111, Colombia.;Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá 110121, Colombia.
[1]
Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá 110111, Colombia.;Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ 85054, USA.
[2]
Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá 110111, Colombia.
[3]
Department of Neurology, Fundación Universitaria de Ciencias de la Salud, Bogotá 111221, Colombia.
[4]
Thoracic Oncology Unit and Personalized Oncology Laboratory, National Cancer Institute (INCan), Mexico City 14080, Mexico.
[5]
Medical Oncology Unit, A.O. Papardo, 98158 Messina, Italy.
[6]
Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
[7]
Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá 110111, Colombia.;Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá 110121, Colombia.;Direction of Research, Science and Education, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá 110131, Colombia.
[8]
DOI
10.3390/pharmaceutics14061243
PMID
35745815
发布时间
2022-07-16
换一批
